The Power of AI in Pharma to Achieve Regulatory-Ready Studies

Today, researchers still face challenges in accessing deep, diverse, longitudinal, fit-for-purpose real-world data. Recent technological advancements like purpose-built large language models can help with these challenges. When paired with novel patient-mediated approaches to data collection and generation, they are finally helping to unlock the full potential of medical data to drive better research and improve healthcare.
Faith Holmes

Optimized Design Offers Fast Track to Inclusive Clinical Trials

Diversity in clinical research has become a hot topic in recent years, with heightened attention leading to dramatic changes in the regulatory framework, including U.S. legislation broadening the scope of diversity consideration in clinical trials. In an article for the forthcoming August issue of ACRP’s Clinical Researcher journal, Faith Holmes, MD, Chief Medical Officer, and Kristen Snipes, CCRA, Executive Director, Project Delivery, both with Elligo Health Research®, examine how, despite this increased awareness and regulatory push, many long-standing challenges persist.

Opinion: Quality vs. Compliance Mentality Pits the ‘Good’ Against the ‘Best’

Within the clinical research enterprise, as can be seen elsewhere in business and regulatory landscapes, the terms “quality” and “compliance” often intersect, creating what some feel is a symbiotic relationship crucial for organizational success. However, despite their frequent association, these terms embody distinct philosophies and practices.